It has long been assumed that cardiac structural abnormalities are undetectable in patients with loss of-function SCN5A channelopathies, in coherence with the conventional concept that Nav1.5 is only involved in maintaining cardiac electrical integrity. The gene discussed is SCN5A; the disease is channelopathy.